Skip to main content

Max Spaderna, MD

Academic Title:

Assistant Professor

Primary Appointment:

Psychiatry

Location:

3rd Floor

Phone (Primary):

410-328-2207

Phone (Secondary):

410-328-8070

Fax:

410-328-2223

Education and Training

2006B.A., University of Massachusetts Amherst, History 

2010M.D., Boston University School of Medicine, Medicine 

2014    Adult Psychiatry Residency, Yale University School of Medicine

Biosketch

I am a faculty member of the Division of Addiction Research and Treatment. My clinical interests include severe and persistent mental illness, substance use disorders, and care of transgender and gender non-conforming individuals. My clinics at the University of Maryland are the Continuous Care Team (CCT), providing intensive care to patients at high risk of re-hospitalization; the Fayette Clinic, providing care to Community Psychiatry patients; and the Addiction Treatment Program, providing care to patients with co-morbid substance use disorders. My research interests include the study of psychiatric illness, psychiatric care, and social determinants of health in substance use disorders.

Research/Clinical Keywords

Substance use disorders, severe and persistent mental illness, social determinants of health, transgender and gender non-conforming patients

Highlighted Publications

    Spaderna, M., Kattakuzhy, S., Kang, S.J., George, N., Bijole, P., Ebah, E., Eyasu, R., Ogbumbadiugha, O., Silk, R., Gannon, C., Davis, A., Cover, A., Gayle, B., Narayanan, S., Pao, M., Kottilil, S., Rosenthal, E. (2023). Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use. International Journal of Drug Policy, 111. 

    Spaderna, M., Bennett, M., Arnold, R., & Weintraub, E. (2021). Case Series of Patients with Opioid Use Disorder and Suicidal Ideation Treated with Buprenorphine. Clinical Practice and Cases in Emergency Medicine, 5(1), 6–10.  

    Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013). Spicing things up: Synthetic cannabinoids. Psychopharmacology, 228(4), 525–540.  

      Additional Publication Citations

      Kelly, D. L., Spaderna, M., Hodzic, V., Nair, S., Kitchen, C., Werkheiser, A. E., Powell, M. M., Liu, F., Coppersmith, G., Chen, S., & Resnik, P. (2020). Blinded Clinical Ratings of Social Media Data are Correlated with In-Person Clinical Ratings in Participants Diagnosed with Either Depression, Schizophrenia, or Healthy Controls. Psychiatry Research, 294, 113496.  

      Kelly, D. L., Spaderna, M., Hodzic, V., Coppersmith, G., Chen, S., & Resnik, P. (2021). Can language use in social media help in the treatment of severe mental illness? Current Research in Psychiatry, 1(1), 1–4.

      Israel, B., Wiprovnik, A.E., Belcher, A.M., Kleinman, M.B., Ramprashad, A., Spaderna, M., Weintraub, E. (2022). Practical Considerations for Treating Comorbid Posttraumatic Stress Disorder in the Addictions Clinic: Approaches to Clinical Care, Leadership, and Alleviating Shame. The Psychiatric Clinics of North America, 45(3), 375-414. 

      Research Interests

      Psychiatric illness, psychiatric care, and social determinants of health in substance use disorders

      Clinical Specialty Details

      Severe and persistent mental illness, substance use disorders, care of transgender and gender non-conforming individuals

      Awards and Affiliations

      American Board of Psychiatry and Neurology

      Grants and Contracts

      09/01/17-presentCo-Inv (10 %); PI: Rosenthal, Elana 

      Research NIH/CC 

      HHSN269201400012C 

      Long Term Outcomes of Opioid Using People: natural history study serving as a longitudinal cohort of persons with OUD 

      Total costs: $2,111,728 

      Direct costs: $1,692,622 

      Role: Psychiatrist 

       

      6/2021-present Co-Inv; PI: Belcher, Annabelle 

      Service (CARES) Science to Systems Grant (SSG) program, University of Maryland Center for Addition Research, Education, and Treatment 

      Increasing Retention in Methadone Maintenance Treatment: Feasibility and Preliminary Efficacy of Adjunct Ketamine for the Treatment of Patients with OUD and Comorbid Depression 

      Direct costs: $46,623 

       

      6/2021-5/03/23Co-PI; PI: Moen, Marik 

      Service (CARES) Science to Systems Grant (SSG) program, University of Maryland Center for Addition Research, Education, and Treatment 

      Improving Patient and Provider Engagement in Addiction Research Through A Longitudinal Research Collaborative and Promoting Understanding in social needs Research Projects by Listening and Engagement 

      Direct costs: $78,850.53 

       

      06/2022-02/2024PI 

      Innovations in Recovery through Infrastructure Support (IRIS), University of Maryland, School of Social Work 

      NIDA R24DA051975 

      Social Work Assistance and Stipends for Housing (SASH): Improving Outcomes for Homeless Patients Receiving Methadone for Opioid Use Disorder 

      Direct Costs: $17,500 

       

      07/2022-02/2024PI 

      Service (CARES) Science to Systems Grant (SSG) program, University of Maryland Center for Addition Research, Education, and Treatment 

      Social Work Assistance and Stipends for Housing (SASH): Improving Outcomes for Homeless Patients Receiving Methadone for Opioid Use Disorder 

      Direct Costs: $46,000 

       

      12/22-11/24Co-Inv; PI: Jay Unick 

      NIMH 

      R01 MH128781-01 

      Bringing Health Home 

      Direct costs: $2,250,000 

       

      07/23-02/25PI 

      Service (CARES) Science to Systems Grant (SSG) program, University of Maryland Center for Addition Research, Education, and Treatment 

      Improving the Linkage and Retention to Outpatient Psychiatric Care in Individuals with OUD 

      Direct Costs: $50,000